PLSE Q1 2023 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+100.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$896,000

Balance Sheet

Total Assets

$70M

Total Liabilities

$81M

Stockholders' Equity

-$11M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$444,000	-100.0%
Gross Profit	$0	-$465,000	+100.0%
Operating Income	-$10M	-$17M	+44.6%
Net Income	-$10M	-$17M	+43.3%